These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 28108813

  • 1. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.
    Si F, Wu Y, Gao F, Feng S, Liu R, Yi Q.
    Clin Exp Med; 2017 Nov; 17(4):451-457. PubMed ID: 28108813
    [Abstract] [Full Text] [Related]

  • 2. Association between IL-35 and coronary arterial lesions in children with Kawasaki disease.
    Su Y, Feng S, Luo L, Liu R, Yi Q.
    Clin Exp Med; 2019 Feb; 19(1):87-92. PubMed ID: 30054763
    [Abstract] [Full Text] [Related]

  • 3. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
    Zhang XY, He T, Ling JY, Hu XF, Wen Y, Wei J, Lu HL.
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):543-548. PubMed ID: 30022755
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.
    Feng S, Su Y, Luo L, Jing F, Yi Q.
    Pediatr Res; 2018 May; 83(5):999-1003. PubMed ID: 29360808
    [Abstract] [Full Text] [Related]

  • 5. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
    Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
    [Abstract] [Full Text] [Related]

  • 6. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
    Li SY, Ding Y.
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar 15; 25(3):244-249. PubMed ID: 36946157
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.
    Weng KP, Hsieh KS, Huang SH, Ou SF, Lai TJ, Tang CW, Lin CC, Ho TY, Liou HH, Ger LP.
    J Chin Med Assoc; 2013 Aug 15; 76(8):438-45. PubMed ID: 23769880
    [Abstract] [Full Text] [Related]

  • 8. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar 21; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 10. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
    Zhang X, Ya-Wang Shao, Ya-Lan Zhang, Yi Liu.
    Heart Surg Forum; 2021 Jul 26; 24(4):E611-E618. PubMed ID: 34473042
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship between adipokines and coronary artery aneurysm in children with Kawasaki disease.
    Liu R, He B, Gao F, Liu Q, Yi Q.
    Transl Res; 2012 Aug 26; 160(2):131-6. PubMed ID: 22683371
    [Abstract] [Full Text] [Related]

  • 13. Do cytokines correlate with refractory Kawasaki disease in children?
    Wang Y, Qian SY, Yuan Y, Wang Q, Gao L, Chen X, Yu X, Zhen Z.
    Clin Chim Acta; 2020 Jul 26; 506():222-227. PubMed ID: 32156603
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical significance of serum soluble TNF receptor II level and soluble TNF receptor II/I ratio as indicators of coronary artery lesion development in Kawasaki disease.
    Shimizu M, Mizuta M, Usami M, Inoue N, Sakakibara Y, Yamada K, Konishi M, Ohta K, Yachie A.
    Cytokine; 2018 Aug 26; 108():168-172. PubMed ID: 29625336
    [Abstract] [Full Text] [Related]

  • 16. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
    Jin J, Wang J, Lu Y, Fan Z, Huang N, Ma L, Yu H.
    Indian J Pediatr; 2019 Mar 26; 86(3):250-255. PubMed ID: 30159809
    [Abstract] [Full Text] [Related]

  • 17. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A, Pal P, Basu S.
    Rheumatol Int; 2019 Oct 26; 39(10):1797-1801. PubMed ID: 31302740
    [Abstract] [Full Text] [Related]

  • 18. Association between adipokines and coronary artery lesions in children with Kawasaki Disease.
    Kim HJ, Choi EH, Kil HR.
    J Korean Med Sci; 2014 Oct 26; 29(10):1385-90. PubMed ID: 25368492
    [Abstract] [Full Text] [Related]

  • 19. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter].
    Yang J, Li CR, Li YB, Li RX, Sun LB, Huang HJ, Wang GB.
    Zhonghua Er Ke Za Zhi; 2003 Aug 26; 41(8):598-602. PubMed ID: 14744383
    [Abstract] [Full Text] [Related]

  • 20. Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.
    Peng Y, Pei Q, Feng S, Su Y, Liu R, Yi Q, Guo P.
    Clin Exp Med; 2019 Nov 26; 19(4):457-462. PubMed ID: 31478099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.